HCM
HUTCHMED (China) Limited
$16.66
-$0.38(-2.23%)
57
Overall
40
Value
75
Tech
--
Quality
Market Cap
$3.04B
Volume
96.90K
52W Range
$11.51 - $21.50
Target Price
$23.25
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $216.1M | $241.2M | $214.1M | $204.9M | $228.0M | $356.1M | $426.4M | $388.9M | $401.4M | ||
| Total Revenue | $171.1M | $241.2M | $214.1M | $204.9M | $228.0M | $356.1M | $426.4M | $838.0M | $630.2M | ||
| COST OF GOODS SOLD | |||||||||||
| Cost of Revenue | $-149.1M | $-168.3M | $-129.3M | $-152.7M | $-178.8M | $-229.4M | $-268.7M | $384.4M | $348.9M | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $59.8M | $65.4M | $70.2M | $44.7M | $39.5M | $97.9M | $115.3M | $453.6M | $281.3M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $106.4M | $118.8M | $162.8M | $191.1M | $236.1M | $426.2M | $523.0M | $443.6M | $329.9M | ||
| Research & Development | $66.9M | $75.5M | $114.2M | $138.2M | $174.8M | $299.1M | $386.9M | $302.0M | $212.1M | ||
| Research Expense | $66.9M | $75.5M | $114.2M | $138.2M | $174.8M | $299.1M | $386.9M | $9.2M | -- | ||
| Selling, General & Administrative | $39.6M | $43.3M | $48.6M | $52.9M | $61.3M | $127.1M | $136.1M | $133.2M | $112.9M | ||
| Selling & Marketing Expenses | $18.0M | $19.3M | $17.7M | $13.7M | $11.3M | $37.8M | $43.9M | $53.4M | $48.6M | ||
| General & Administrative Expenses | $21.6M | $24.0M | $30.9M | $39.2M | $50.0M | $89.3M | $92.2M | $79.8M | $64.3M | ||
| Salaries & Wages | $-21.7M | $-24.8M | $-35.3M | $-46.2M | $-63.5M | -- | $-119.3M | -- | -- | ||
| Depreciation & Amortization | $-2.3M | $-2.6M | $-3.6M | $-4.9M | $-6.1M | -- | $-8.7M | -- | -- | ||
| Depreciation & Amortization | $-2.3M | $-2.6M | $-3.6M | $-4.9M | $-6.1M | -- | $-8.7M | -- | -- | ||
| Amortization | $-92.0K | $-147.0K | $-76.0K | $-195.0K | $-43.0K | -- | $-18.0K | -- | -- | ||
| Other Operating Expenses | $-29.0K | $-242.0K | $-21.0K | $-16.0K | $-95.0K | $-16.0K | $-150.0K | $8.4M | $4.9M | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-46.7M | $-53.4M | $-92.6M | $-146.4M | $-196.7M | $-328.3M | $-407.7M | $10.0M | $-48.6M | ||
| EBITDA | $-45.7M | $-52.1M | $-85.6M | $-140.1M | $-188.9M | $-215.1M | $-409.8M | $67.3M | $14.1M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | $1.6M | $1.5M | $1.0M | $1.0M | $787.0K | $592.0K | $652.0K | $759.0K | $2.9M | ||
| Intinc | $502.0K | $1.2M | $6.0M | $4.9M | $3.2M | $2.1M | $9.6M | $36.1M | $40.1M | ||
| Net Non-Operating Interest Income/Expense | $-1.1M | $-235.0K | $5.0M | $3.9M | $2.4M | $1.5M | $8.9M | $35.4M | $37.2M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | -- | $8.7M | -- | ||
| Other Income/Expense | $-66.7M | $-33.8M | $-20.4M | $-42.1M | $-83.5M | $-171.7M | $-38.1M | $-12.9M | $-10.3M | ||
| Other Special Charges | $470.0K | $116.0K | $1.0M | $1.4M | $4.5M | $-10.2M | $-11.7M | $12.9M | $10.3M | ||
| SPECIAL ITEMS | |||||||||||
| Restructring And Mn A Income | $-4.3M | $-6.1M | $-6.5M | $-12.8M | $-25.2M | -- | $-49.0M | -- | -- | ||
| Special Income Charges | $4.3M | $6.1M | $6.5M | $12.8M | $25.2M | -- | $49.0M | $-5.8M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $5.8M | -- | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-45.7M | $-52.1M | $-85.6M | $-140.1M | $-188.9M | $-215.1M | $-409.8M | $59.1M | $1.8M | ||
| Pre-Tax Income | $-47.4M | $-53.5M | $-86.7M | $-141.1M | $-189.7M | $-215.7M | $-410.4M | $58.3M | $-1.1M | ||
| INCOME TAX | |||||||||||
| Tax Provision | $4.3M | $3.1M | $4.0M | $3.3M | $4.8M | $11.9M | $-283.0K | $-42.8M | $-39.3M | ||
| NET INCOME | |||||||||||
| Net Income | $11.7M | $-26.7M | $-74.8M | $-106.0M | $-125.7M | $-194.6M | $-360.8M | $100.8M | $37.7M | ||
| Net Income (Continuing Operations) | $11.7M | $-26.7M | $-74.8M | $-106.0M | $-125.7M | $-194.6M | $-360.8M | $101.1M | $38.2M | ||
| Net Income (Discontinued Operations) | $11.7M | $-26.7M | $-74.8M | $-106.0M | $-125.7M | $-194.6M | $-360.8M | $100.8M | $37.7M | ||
| Net Income (Common Stockholders) | $11.7M | $-26.7M | $-74.8M | $-106.0M | $-125.7M | $-194.6M | $-360.8M | $100.8M | $37.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | $15.5M | $-40.4M | ||
| TOTALS | |||||||||||
| Total Expenses | $-42.7M | $-49.5M | $33.5M | $38.4M | $57.3M | $196.8M | $254.3M | $828.0M | $678.8M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $59.7M | $61.7M | $664.3M | $665.7M | $697.9M | $792.7M | $847.1M | $849.7M | -- | ||
| Average Shares Outstanding (Diluted) | $60.0M | $61.7M | $680.0M | $662.6M | $697.9M | $792.7M | $847.1M | $869.2M | -- | ||
| Shares Outstanding | $60.7M | $66.4M | $66.7M | $666.9M | $727.7M | $864.5M | $864.8M | $174.4M | $854.9M | ||
| Basic EPS | $0.20 | $-0.43 | $-0.11 | $-0.16 | $-0.18 | $-0.25 | $-0.43 | $0.12 | -- | ||
| Basic EPS (Continuing Operations) | $0.20 | -- | -- | -- | -- | -- | -- | $0.12 | -- | ||
| Diluted EPS | $0.20 | $-0.43 | $-0.11 | $-0.16 | $-0.18 | $-0.25 | $-0.43 | $0.12 | -- | ||
| Diluted EPS (Continuing Operations) | $0.20 | -- | -- | -- | -- | -- | -- | $0.12 | -- | ||
| OTHER METRICS | |||||||||||
| Earnings from equity interest | $66.2M | $33.7M | $19.3M | $40.7M | $79.0M | $60.6M | $49.8M | $47.3M | -- | ||
| Earnings From Equity Interest Net Of Tax | $66.2M | $33.7M | $19.3M | $40.7M | $79.0M | $60.6M | $49.8M | $47.3M | -- | ||
| Gain On Sale Of P P E | $-30.0K | $-57.0K | $-33.0K | $-17.0K | $-85.0K | -- | $-111.0K | -- | -- | ||
| Minority Interests | $-2.9M | $-3.8M | $-3.5M | $-2.3M | $-10.2M | $-27.6M | $-449.0K | $-314.0K | $-441.0K | ||
| Net Income Discontinuous Operations | $260.0K | $394.0K | $355.0K | $812.0K | $5.0M | -- | $1.6M | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | -- | $384.4M | $348.9M | ||
| Other Gand A | $21.6M | $24.0M | $30.9M | $39.2M | $50.0M | $89.3M | $92.2M | $79.8M | $64.3M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $-130.0K | -- | -- | ||
| Other Write Off | $-237.0K | $-2.9M | $-1.0K | -- | -- | -- | -- | -- | -- | ||
| Provision For Gain Loss On Disposal | $260.0K | $394.0K | $355.0K | $812.0K | $5.0M | -- | $1.6M | -- | -- | ||
| Rent And Landing Fees | $21.6M | $24.0M | $30.9M | $39.2M | $50.0M | $89.3M | $92.2M | -- | -- | ||
| Selling Expense | $18.0M | $19.3M | $17.7M | $13.7M | $11.3M | $37.8M | $43.9M | -- | -- | ||
| Restruct | $-4.3M | $-6.1M | $-6.5M | $-12.8M | $-25.2M | -- | $-49.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCM | $16.66 | -2.2% | 96.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get HUTCHMED (China) Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW